Brendan G. Cooper

Brendan G. Cooper

Auto-generated profile, based on publicly available information

Brendan G. Cooper

Lung Function and Sleep, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
BGBrian L. Graham
Brian L. Graham
ISIrene Steenbruggen
Irene Steenbruggen
MMMartin R. Miller
Martin R. Miller
IBIgor Barjaktarevic
Igor Barjaktarevic
BCBrendan G. Cooper
Brendan G. Cooper
BTBruce R. Thompson
Bruce R. Thompson
Background: Spirometry is the most common pulmonary function test. It is widely used in the assessment of lung function to provide objective information used in the diagnosis of lung diseases and monitoring lung health. In 2005, the American Thoracic Society and the European Respiratory Society jointly adopted technical standards for conducting spirometry. Improvements in instrumentation and computational capabilities, together with new research studies and enhanced quality assurance approaches, have led to the need to update the 2005 technical standards for spirometry to take full advantage of current technical capabilities. Methods: This spirometry technical standards document was developed by an international joint task force, appointed by the American Thoracic Society and the European Respiratory Society, with expertise in conducting and analyzing pulmonary function tests, laboratory quality assurance, and developing international standards. A comprehensive review of published evidence was performed. A patient survey was developed to capture patients’ experiences. Results: Revisions to the 2005 technical standards for spirometry were made, including the addition of factors that were not previously considered. Evidence to support the revisions was cited when applicable. The experience and expertise of task force members were used to develop recommended best practices. Conclusions: Standards and consensus recommendations are presented for manufacturers, clinicians, operators, and researchers with the aims of increasing the accuracy, precision, and quality of spirometric measurements and improving the patient experience. A comprehensive guide to aid in the implementation of these standards was developed as an online supplement.

6 September 2017 in Breathe
Verified
Journal Article
Open access
PDF file
BCBrendan G. Cooper
Brendan G. Cooper
JSJanet Stocks
Janet Stocks
GHGraham L. Hall
Graham L. Hall
BCBruce Culver
Bruce Culver
ISIrene Steenbruggen
Irene Steenbruggen
SSSanja Stanojevic
Sanja Stanojevic
The Global Lung Function Initiative (GLI) Network has become the largest resource for reference values for routine lung function testing ever assembled. This article addresses how the GLI Network came about, why it is important, and its current challenges and future directions. It is an extension of an article published inBreathein 2013 [1], and summarises recent developments and the future of the GLI Network.Key points: The Global Lung Function Initiative (GLI) Network was established as a result of international collaboration, and altruism between researchers, clinicians and industry partners. The ongoing success of the GLI relies on network members continuing to work together to further improve how lung function is reported and interpreted across all age groups around the world. The GLI Network has produced standardised lung function reference values for spirometry and gas transfer tests. GLI reference equations should be adopted immediately for spirometry and gas transfer by clinicians and physiologists worldwide. The recently established GLI data repository will allow ongoing development and evaluation of reference values, and will offer opportunities for novel research. Educational aims: To highlight the advances made by the GLI Network during the past 5 years. To highlight the importance of using GLI reference values for routine lung function testing (e.g. spirometry and gas transfer tests). To discuss the challenges that remain for developing and improving reference values for lung function tests.


20 July 2010 in Thorax
Verified
Journal Article
Open access
PDF file
BCBrendan G Cooper
Brendan G Cooper
Guidelines on contraindications for lung function tests have been based on expert opinion from >30 years ago. High-risk contraindications to lung function testing are associated with cardiovascular complications such as myocardial infarct, pulmonary embolism or ascending aortic aneurysm. Slightly less risky but still serious contraindications are predominantly centred on recovery from major thoracic, abdominal or head surgery. Less serious surgical procedures will present a possible risk, but the RR depends upon whether the lung function is essential or can wait until the patient's condition improves. In recent decades there have been moves towards less invasive surgical techniques, keyhole surgery and new technology such as laser surgery which minimise the amount of collateral damage to surrounding tissues. In thoracic surgery there is a shift in emphasis to quicker postsurgical mobility. Furthermore there has been little analysis of the scientific facts behind the current recommendations and contraindications. The principle absolute and relative contraindications are in need of revision, and recommended times of abstaining from lung function tests needs to be reviewed. This review aims to outline the key issues and suggests newer recommendations for contraindications for performing lung function using a risk matrix, as well as offering alternative approaches to testing patients who may be at risk of complication from testing. In general, the previous recommendation of waiting for 6 weeks after surgical procedures or medical complications before performing lung function can often now be reduced to <3 weeks with modern less invasive surgical techniques.

1 September 1993 in Metabolism
Verified
Journal Article
Closed access
AJA.B. Johnson
A.B. Johnson
JWJ.M. Webster
J.M. Webster
CSC.-F. Sum
C.-F. Sum
LHL. Heseltine
L. Heseltine
MAM. Argyraki
M. Argyraki
RTR. Taylor
R. Taylor

3 January 2017 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
BGBrian L. Graham
Brian L. Graham
VBVito Brusasco
Vito Brusasco
FBFelip Burgos
Felip Burgos
BCBrendan G. Cooper
Brendan G. Cooper
RJRobert Jensen
Robert Jensen
JWJack Wanger
Jack Wanger
This document summarises an update to the European Respiratory Society (ERS)/American Thoracic Society (ATS) technical standards for single-breath carbon monoxide uptake in the lung that was last updated in 2005. The full standards are also available online ashttps://doi.org/10.1183/13993003.00016-2016. The major changes in these technical standards relate toDLCOmeasurement with systems using rapidly responding gas analysers for carbon monoxide and the tracer gas, which are now the most common type ofDLCOinstrumentation being manufactured. Technical improvements and the increased capability afforded by these new systems permit enhanced measurement ofDLCOand the opportunity to include other optional measures of lung function.